Saltar al contenido
Merck

A protocol to induce expandable limb-bud mesenchymal cells from human pluripotent stem cells.

STAR protocols (2022-11-02)
Tomoka Takao, Daisuke Yamada, Takeshi Takarada
RESUMEN

Here, we present a protocol for the selective differentiation of human pluripotent stem cells mimicking human developmental processes into expandable PRRX1+ limb-bud mesenchymal (ExpLBM) cells. This approach enables expansion through serial passage while maintaining capacity for chondrogenic differentiation. For complete details on the use and execution of this protocol, please refer to Yamada et al. (2021, 2022).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Proteína purificada fibronectina plasmática humana, from human plasma, liquid, 1 mg/mL (100 MG pack size is lyophilized), purified protein, suitable for cell culture
Sigma-Aldrich
Anticuerpo anti-Sox9, Chemicon®, from rabbit
Sigma-Aldrich
PI 3-K inhibitor IX, PIK-90, The PI 3-K inhibitor IX, PIK-90, also referenced under CAS 677338-12-4, controls the biological activity of PI 3-K. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.